« Older Entries

Natural Ways To Regulate High BP And Hypertension In A Safe Manner

It is very necessary to regulate blood pressure or hypertension, because if it is left untreated it can lead to a number of health problems in both men and women. There are both natural ways to regulate BP as well as herbal methods. It would be first useful to look at the natural ways to regulate hypertension.

Some of the effective natural ways to regulate blood pressure are:

Regulate blood pressure by maintaining the most ideal weight and waistline; being overweight disrupts breathing while you sleep and raises BP.

One of the natural ways to regulate hypertension is to exercise regularly; some of the best forms of exercise include walking, jogging, cycling, swimming or dancing, with strength training also helping to bring down BP.

Reduce hypertension by eating a diet that is rich in whole grains, fruits, vegetables and low-fat dairy products; avoid foods that are rich in saturated fat and cholesterol to lower BP.

The natural ways to regulate BP includes limiting the amount of alcohol you drink; drinking in excess could also reduce the effectiveness of BP medications.

Quit smoking; this natural way to bring down BP also helps increase life expectancy.

Reduce your stress as a natural way to regulate BP; chronic stress contributes to hypertension, while occasional stress with eating unhealthy food, drinking alcohol or smoking also contributes to hypertension.

One of the natural ways to regulate hypertension lies in cutting back on caffeine; there is however a debate on this point. Talk to your doctor about the effects of caffeine on your blood pressure.

Reduce stress as a natural way to regulate hypertension; chronic stress is elevates blood pressure, while occasional stress contributes to hypertension if you react to stress by eating unhealthy food, drinking alcohol or smoking.

Be sure to follow one of the natural ways to regulate BP; monitor your blood pressure at home and see your doctor regularly.

Next natural way to regulate BP lies in having a supportive family and friends that could encourage you to take care of yourself, drive you to the doctor’s office or embark on an exercise program with you to keep your blood pressure low.

Besides making some lifestyle changes like reducing salt in diet and exercising, the individual can rely on herbal remedies to control high BP as these remedies are safe and they do not increase dependency as well.

One of the most effective natural ways to regulate hypertension lies in taking herbal combinations like Stresx capsules. These capsules help to lower problems of restlessness and fatigue and also correct poor functioning of heart. In addition this effective herbal combination also proves effective in health issues like sleeplessness and insomnia. It also facilitates a health blood flow to the central and peripheral nervous system and helps in the maintenance of healthy arteries.

Stresx capsules, one of the best natural ways to regulate BP contain herbs like Arjuna, Brahmi, Shankpushpi, Ashwagandha, Ganjwan, Sudh Shilajit, Aam, Chotachand, Jyotishmati, Jadwar, Vacha and Safed Musli.

Be sure to include Stresx capsules along with other natural ways to regulate hypertension and enjoy a life free of hypertension and its complications.

—

Tags:

Why Is The Transit Visa Necessary In Thailand?

If you are travelling to another destination and you need to stop over in Thailand for a few hours, you will need a Thailand transit Visa to ensure you have no problems in-between your flights. Since the penalties for failure to present a valid visa are very high in Thailand, it may result in you paying a heavy fine or even the possibility of unnecessary deportation. The transit visa Thailand will save you from this problem. The transit visa varies from country to country but the application is almost the same.

Requirements of a transit visa Thailand:

The transit visa follows the same pattern as the other transit visa applications all around the world. You need to get an application form from online or from the visa application center and fill it with accurate information. Once you have filled the form you will need to collect the necessary documents.

The individual must provide the following when applying for a transit visa to Thailand:

• Passport with 6 months validity and two pages free

• Passport size recent pictures

• A confirmed itinerary of the journey

• Confirmed reservation for accommodation or lodging under the applications name

• Letter of invitation with the inviter’s id and passport copy

• Sufficient funds available in the bank during the applicants stay or original bank statement from the last 6 months

• Name and address of local guarantor with telephone number, and fax numbers of travel agent. In the case of alone individuals they must provide the name, address, telephone number, and fax numbers of parents, relatives, or friends, in India.

• Name and address of guarantor in Thailand with telephone number, and fax numbers of the partnered travel agent/company or group/personal tour-guide in Thailand.

After submitting the necessary documents, you will have to pay a fee of 1600 RS via a demand draft only, per entry. The transit visa Thailand is valid for a period of three months. The validity of the stay is not more than 30 days. Normally the processing period is about 3 working days. But if it is an emergency, you can get it within 24 hours. If you wish to stay longer, or extend your visa, you must file an application for permission from the Office of Immigration Bureau. However, the extension of the stay as well as the change of the visa relied solely on the decision of the office. You can check the status of your visa online or you can contact the visa application center. Once you receive the approval for your transit visa Thailand, you can either personally collect it from the center. All you have to do is, carry a proof of id, and visit the center. You can also have your visa couriered to your home address with an additional service charge of Rs. 200.

Tags:

Oncology Biosimilars Market Opportunity Analysis, 2018-2026

Biosimilar is a biological product that resembles a reference product and is not difference from the already approved reference product. These are relatively cheaper than branded or approved products. Several biologics for oncology have already lost their patents, and some are in its period of expiry. As more products are expected to lose patents, biosimilar is expected to gain popularity. Leading generic players such as Mylan N.V., Teva Pharmaceutical Industries Ltd, Allergan Plc, Sandoz (a Novartis International AG’s division) are expected to capitalize on these patent expiries and may establish themselves as dominating players in oncology biosimilars market.

Click To Continue Reading on Oncology Biosimilars Market

There was about a decade gap in approval of first biosimilars in two key markets, Europe and the U.S. First biosimilar was approved in 2006 in Europe, however, in the U.S. first product was approved in 2015. But since approving the first biosimilar, the FDA has approved five products in 2017. Out of these five biosimilars, two were approved for oncology. First, oncology biosimilar Mvasi (bevacizumab-awwb) received approval in September 2017, and second one, Ogivri (trastuzumab) was approved in December 2017. In Europe, both of the products have been approved, and Mvasi received approval from European Commission in January 2018.

Moreover, there are number of biosimilar application pending in the U.S. and Europe. For Herceptin (trastuzumab) alone, there are around four application pending in the FDA. These four application are from Amgen and Allergan, Celltrion and Teva, Pfizer, and Samsung Bioepis. Recent approval of products, and potential approval in next few years is expected to boost the market growth over the forecast period.

On the basis of region, oncology biosimilars market by Coherent Market Insights is segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa. North America is expected to be the dominant market over the forecast period. U.S. FDA approved first biosimilar in 2015, almost a decade later than first biosimilar approval in Europe. However, since 2015, the number of approved products has increased rapidly. This is expected to be factor for growth of the market in North America. Moreover, currently there are number of products in pipeline, which may receive approval from the FDA over the forecast period. For instance, Pfizer Inc. — a U.S.-based company — has three biosimilar products (i.e. PF-05280014, PF-05280586 and PF-06439535) for oncology in Phase 3.

Tags: